HIGHLIGHTS
- who: Mai Mansour from the Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain Shams University, African have published the paper: Intranasal ondansetron microemulsion counteracting the adverse effects of cisplatin: animal study, in the Journal: (JOURNAL)
- what: The aim of this work was to explore whether a selective 5-HT3 receptor antagonist (Ondansetron) administered via the oral route or intranasally in form would alleviate cisplatin`s adverse effects. The aim of this work is to investigate the intranasal delivery of ondansetron in microemulsion form, the enhancement of the therapeutic potential of the drug as . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.